- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Lemboraxant is a novel dual orexin receptor antagonist primarily used to treat adult insomnia, particularly targeting symptoms of difficulty fa...
Lemboraxant is a novel dual orexin receptor antagonist specifically used to treat insomnia characterized by difficulty falling asleep or mainta...
Entretinib is an oral tyrosine kinase inhibitor targeting the fusion of ROS1 and NTRK genes, mainly used for the treatment of ROS1 positive non...
Rezdifra is a novel drug, but its specific information is not included in the current search results. According to the existing information, th...
Rezdifra is a novel targeted therapy drug, but specific information about the drug is currently not provided in search results. According to th...
Entretinib is an oral tyrosine kinase inhibitor that targets the fusion of ROS1 and NTRK genes. It is mainly used to treat ROS1 positive non-sm...
Tivozanib is an oral inhibitor of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase, mainly used for the treatment of advance...
Tivozanib is an oral inhibitor of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase, mainly used for the treatment of advance...
Selumetinib is a MEK1/2 inhibitor targeted drug mainly used to treat type 1 neurofibromatosis (NF1) - related plexiform neurofibromatosis. It i...
Selumetinib is a MEK1/2 inhibitor targeted drug primarily used to treat type 1 neurofibromatosis (NF1) - related plexiform neurofibromatosis. I...
